Syringoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 13: | Line 13: | ||
| Molecular = | | Molecular = | ||
| IF = | | IF = | ||
| Gross = | | Gross = usually lower eyelid lesion | ||
| Grossing = [[unoriented skin ellipse grossing]], [[oriented skin ellipse grossing]] | | Grossing = [[unoriented skin ellipse grossing]], [[oriented skin ellipse grossing]] | ||
| Staging = | | Staging = | ||
| Line 19: | Line 19: | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = classically female | ||
| Signs = | | Signs = | ||
| Symptoms = | | Symptoms = | ||
| Line 36: | Line 36: | ||
*Benign sweat duct tumour. | *Benign sweat duct tumour. | ||
*Eccrine differentiation. | *Eccrine differentiation. | ||
* | *Classically lower [[eyelid]].<ref>{{Ref PBoD8|1177}}</ref><ref name=pmid17326243/> | ||
*Typical female - female:male = 6.6:1.<ref>{{cite journal |authors=Lee JH, Chang JY, Lee KH |title=Syringoma: a clinicopathologic and immunohistologic study and results of treatment |journal=Yonsei Med J |volume=48 |issue=1 |pages=35–40 |date=February 2007 |pmid=17326243 |pmc=2628001 |doi=10.3349/ymj.2007.48.1.35 |url=}}</ref> | *Typical female - female:male = 6.6:1.<ref name=pmid17326243>{{cite journal |authors=Lee JH, Chang JY, Lee KH |title=Syringoma: a clinicopathologic and immunohistologic study and results of treatment |journal=Yonsei Med J |volume=48 |issue=1 |pages=35–40 |date=February 2007 |pmid=17326243 |pmc=2628001 |doi=10.3349/ymj.2007.48.1.35 |url=}}</ref> | ||
==Microscopic== | ==Microscopic== | ||